Nu Skin Enterprises, Inc.

What they do

Nu Skin sells personal care and wellness products, including beauty device systems and the recently introduced Prysm iO intelligent wellness platform, through a global direct-selling and network-marketing sales force rather than primarily through retail. The company reports nine segments: seven geographic Nu Skin segments (Americas, Mainland China, Southeast Asia/Pacific, Japan, Europe & (truncated in the filing) and others) plus the Rhyz strategic investment arm. Rhyz, formed in 2018, holds synergistic consumer, technology and manufacturing businesses in beauty, wellness and lifestyle categories.

Revenue drivers

• Seven geographic Nu Skin segments — Product sales made through Nu Skin's affiliate sales force across the Americas, Mainland China, Southeast Asia/Pacific, Japan, Europe and other markets; these comprise the core direct-selling business.
• Rhyz strategic investment arm — Consumer, technology and manufacturing investments formed in 2018; the segment recorded a $25.1 million intangible asset group impairment in 2025.
• Beauty devices and wellness platform — Award-winning beauty device systems plus the new Prysm iO intelligent wellness platform, which management is rolling out as part of its 2026 priorities.
• Discontinued/divested businesses — Mavely was sold in January 2025 for a pre-tax gain of approximately $176.2 million, and the separate BeautyBio business was wound down in the first quarter of 2026.

Recent performance

Second quarter 2026 revenue fell 17.1% to $320.1 million from $386.1 million a year earlier, with a negative 1.0% foreign-currency impact of about $4.0 million. Customers declined 14% to 660,037, Paid Affiliates fell 8% to 120,291 and Sales Leaders fell 9% to 26,998 year over year. Q2 2026 EPS was $(5.14) versus $0.43, including a $78.9 million impairment charge and a $167.5 million valuation allowance on U.S. deferred tax assets; excluding those non-cash items, EPS was $0.20. Six-month 2026 revenue fell 14.6% to $640.7 million and EPS was $(5.12) versus $2.59. Gross margin was 68.2% compared to 68.8%, and the operating margin was (18.5)%, or 6.1% excluding the impairment.

Strategy

Management's stated 2026 priorities are business model optimization, continued rollout of the Prysm iO intelligent wellness platform and expansion into India. Early learnings from Prysm iO shifted strategy from a device placement focus toward an assessment model conducive to in-person engagement. India previews identified a need to simplify the model before a full market opening now slated for the first half of 2027. The company also says it is re-aligning organizational resources to drive sustainable long-term shareholder value, and it continues to pay a dividend, with $2.9 million paid in Q2 2026 and $137.3 million remaining in its repurchase authorization.

Risks

• FTC and regulatory scrutiny of network marketing — The FTC sent a 2021 notice to more than 1,100 companies including Nu Skin, issued 2024 multi-level-marketing guidance and in 2025 proposed rules on earnings claims that could require changes to Nu Skin's global sales compensation plan.
• Sales force and customer attrition — Customers fell 14%, Paid Affiliates 8% and Sales Leaders 9% year over year in Q2 2026, and management attributes declines to macroeconomic challenges affecting consumer spending and customer acquisition.
• Impairments and tax valuation allowance — Q2 2026 results included a $78.9 million impairment charge and a $167.5 million valuation allowance against U.S. deferred tax assets, driving the $(5.14) quarterly EPS.
• New initiative execution risk — Prysm iO strategy has already been shifted and the India market opening has been delayed to the first half of 2027, with management citing a need to simplify the model.

Outlook

Management guided third quarter 2026 revenue of $310 to $340 million, or (15)% to (7)% year over year, with adjusted EPS of $0.10 to $0.20. Full-year 2026 revenue guidance is $1.28 to $1.35 billion, or (14)% to (9)%, with adjusted EPS of $0.70 to $0.90 and GAAP EPS of $(4.90) to $(4.73). The company expects roughly a (3) to (2)% FX impact in Q3 and about (1)% for the full year. Interim CFO Chelsea Lantz said adjusted EPS came in near the midpoint of guidance on continued focus on profitability and disciplined execution.